Denmark’s pharmaceutical firm H. Lundbeck (LUN.CO: Quote, Profile, Research) could face generic competition for its top-selling anti-depressant Celexa from six to seven companies in the United States, a generic drug-maker said on Tuesday.
Denmark’s pharmaceutical firm H. Lundbeck (LUN.CO: Quote, Profile, Research) could face generic competition for its top-selling anti-depressant Celexa from six to seven companies in the United States, a generic drug-maker said on Tuesday.